Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This trial is conducted in Oceania. The aim of this trial is to investigate the efficacy of activated recombinant human factor VII and standard treatment compared with standard haemostatic replacement therapy in cardiopulmonary bypass (CPB) surgery for paediatric congenital heart disease.
Epistemonikos ID: e63b798ca68f448ab0ff7b4408833c75dfb4ebb3
First added on: May 10, 2024